Please login to the form below

Not currently logged in
Email:
Password:

Bayer finances sustainable development chair at Chinese university

Bayer says it will finance a chair in sustainable development at Tongji University in China

German-based pharmaceutical company Bayer has said it will finance a chair in sustainable development at Tongji University in China.

The chair is a joint project with Tongji University and the UN Environment Programme (UNEP). Bayer will support the new chair, student scholarships and research activities for an initial period of five years with a sponsorship of USD 1m.

The Bayer-Tongji Chair for Sustainable Development will focus on advanced education and research into emerging environmental technologies. It will also support sustainable development projects which enhance China's solutions to environmental, economic and social sustainability problems.

Member of Bayer's management board, Wolfgang Plischke, said: "The path China takes to achieve sustainable growth and protect its environment will have far-reaching effects. We know the government is committed to meeting the challenges, and Bayer is here to help."

Zhao Jianfu, vice-president of Tongji University, added: "The University considers environmental protection and sustainable development one of its top priorities. We are delighted to be working closely with Bayer, a company known worldwide for its outstanding achievements in the area of sustainability."

China plans to reduce its energy consumption and emissions by 20 and 10 per cent, respectively, between 2006 and 2010. To achieve this, the country says it needs help for funding and technologies.

Bayer already provided new technologies and specialised services for China in wastewater treatment, environmental protection and conversion of biological energy sources, added Plischke.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....